Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Solomon

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
European Journal of Public Health|August 27, 2021
Facilitators and barriers to implementing lifestyle intervention programme to prevent cognitive declineJenni Kulmala, Anna Rosenberg, Tiia Ngandu, et al.
European Journal of Neurology|February 7, 2024
The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trialAnette Hall, Mariagnese Barbera, Jenni Lehtisalo, et al.
Frontiers in Neurology|November 12, 2021
Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future DirectionsRuth Stephen, Mariagnese Barbera, Ruth Peters, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Decreased plasma C-reactive protein levels in <i>APOE ε</i>4 allele carriersHenna Martiskainen, Mari Takalo, Alina Solomon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trialGazi Saadmaan, Maria Carolina Dalmasso, Alfredo Ramirez, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6Alina Solomon, Ruth Stephen, Daniele Altomare, et al.
Aging Clinical and Experimental Research|February 19, 2022
Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trialElisa Neuvonen, Jenni Lehtisalo, Alina Solomon, et al.
Journal of Clinical Medicine|March 10, 2022
Associations of Depressive Symptoms and Cognition in the FINGER Trial: A Secondary Analysis of a Randomised Clinical TrialElisa Neuvonen, Jenni Lehtisalo, Tiia Ngandu, et al.
Brain, Behavior, & Immunity - Health|February 23, 2023
Longitudinal study of Alzheimer's disease biomarkers, allostatic load, and cognition among memory clinic patientsDickson O Adedeji, Jasper Holleman, Robert-Paul Juster, et al.
Brain : a Journal of Neurology|August 29, 2013
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy studyBabak Hooshmand, Tuomo Polvikoski, Miia Kivipelto, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Public Health|August 27, 2021
Facilitators and barriers to implementing lifestyle intervention programme to prevent cognitive declineJenni Kulmala, Anna Rosenberg, Tiia Ngandu, et al.
European Journal of Neurology|February 7, 2024
The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trialAnette Hall, Mariagnese Barbera, Jenni Lehtisalo, et al.
Frontiers in Neurology|November 12, 2021
Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future DirectionsRuth Stephen, Mariagnese Barbera, Ruth Peters, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Decreased plasma C-reactive protein levels in <i>APOE ε</i>4 allele carriersHenna Martiskainen, Mari Takalo, Alina Solomon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trialGazi Saadmaan, Maria Carolina Dalmasso, Alfredo Ramirez, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6Alina Solomon, Ruth Stephen, Daniele Altomare, et al.
Aging Clinical and Experimental Research|February 19, 2022
Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trialElisa Neuvonen, Jenni Lehtisalo, Alina Solomon, et al.
Journal of Clinical Medicine|March 10, 2022
Associations of Depressive Symptoms and Cognition in the FINGER Trial: A Secondary Analysis of a Randomised Clinical TrialElisa Neuvonen, Jenni Lehtisalo, Tiia Ngandu, et al.
Brain, Behavior, & Immunity - Health|February 23, 2023
Longitudinal study of Alzheimer's disease biomarkers, allostatic load, and cognition among memory clinic patientsDickson O Adedeji, Jasper Holleman, Robert-Paul Juster, et al.
Brain : a Journal of Neurology|August 29, 2013
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy studyBabak Hooshmand, Tuomo Polvikoski, Miia Kivipelto, et al.
Pageof 15